NL99772C - - Google Patents
Info
- Publication number
- NL99772C NL99772C NL99772DA NL99772C NL 99772 C NL99772 C NL 99772C NL 99772D A NL99772D A NL 99772DA NL 99772 C NL99772 C NL 99772C
- Authority
- NL
- Netherlands
Links
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL99772C true NL99772C (fr) |
Family
ID=1840106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL99772D NL99772C (fr) |
Country Status (1)
| Country | Link |
|---|---|
| NL (1) | NL99772C (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008255138B2 (en) * | 1999-10-25 | 2011-02-24 | Harbor Biosciences, Inc. | Therapeutic treatments for blood cell deficiencies |
-
0
- NL NL99772D patent/NL99772C/xx active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008255138B2 (en) * | 1999-10-25 | 2011-02-24 | Harbor Biosciences, Inc. | Therapeutic treatments for blood cell deficiencies |
| AU2008255138A8 (en) * | 1999-10-25 | 2011-10-20 | Harbor Biosciences, Inc. | Therapeutic treatments for blood cell deficiencies |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2011200199B2 (en) | Steroid analogs and characterization and treatment methods | |
| AU2008255138B2 (en) | Therapeutic treatments for blood cell deficiencies | |
| AU2008201188B2 (en) | Use of certain steroids for treatment of blood cell deficiencies | |
| US6436435B1 (en) | Liposome formulation of 5 β steroids | |
| JP2003512474A5 (fr) | ||
| AU2002244247A1 (en) | Use of certain steroids for treatment of blood cell deficiencies | |
| JP2004537506A5 (fr) | ||
| US4602008A (en) | Alkylated etiocholanolones and use as an anti-diabetic, anti-obesity and erythropoietic agent | |
| NL99772C (fr) |